Implantable Glucose Sensor for Continuous Data Transmission
GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor. The sensor is designed to be implanted under the skin and can transmit continuous glucose values to an external unit or smartphone for over a year, significantly improving the quality of life for patients with diabetes. The sensor is composed of a sensing unit which detects glucose and provides a glucose-dependent optical signal using a biosensor, and a detection unit which reads the optical signals and transmits the data to the external unit. GluSense is part of the Rainbow Medical innovation house.
| Name | GluSense |
|---|---|
| Slug | glusense |
| Type / kind | startup |
| Crunchbase ID | glusense |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6u26QKDA |
| Status | inactive |
|---|---|
| Status reason | Non Active, Feb 2021 ceased to operate |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | 3 Pekeris st., Rehovot, Israel |
| Website | http://www.glusensemedical.com |
|---|---|
| https://www.linkedin.com/company/69488950 |
| Total raised | $7.0M |
|---|---|
| Current stage | Series C |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}